Literature DB >> 11816540

Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer.

M Tachibana1, H Yoshimura, S Kinugasa, D K Dhar, M Shibakita, S Ohno, S Ueda, T Fujii, N Nagasue.   

Abstract

BACKGROUND: The number of metastatic lymph nodes is applied to the staging system of gastric cancer and colorectal cancer. However, it has not been evaluated in oesophageal cancer. PATIENTS AND METHODS: Of 258 patients with primary squamous cell carcinoma of the thoracic oesophagus between February 1981 and December 1999, 160 underwent three-field oesophagectomy with a curative intent. Clinicopathologic characteristics of those 160 patients were retrospectively investigated according to the number of metastatic lymph nodes.
RESULTS: Seventy-eight patients had no lymph node metastases and 82 (51.3%) had lymph node metastases; 51 [31.9%)] had between 1 and 4 positive lymph nodes, and 31 (19.4%) had > or =5. The number of metastatic lymph nodes was significantly correlated with tumour size, macroscopic classification, histological differentiation, pT, pN, and vessel invasions. Multivariate analysis showed that lymph vessel invasion (relative risk 12.6), histological differentiation (relative risk 4.2), and tumour size (relative risk 3.8) were independent factors correlated with number of metastatic lymph nodes. The number of metastatic lymph nodes was also well correlated with the Japanese nodal level and TNM stage, respectively (p<0.001). The 5-year disease-specific survival rate according to the number of positive lymph nodes was 90% for patients without lymph node metastases, 52.2% with 1-4, and 28.9% with > or =5, respectively, p<0. 0001; 0 vs 1-4, p<0.05; 1-4 vs > or =5).
CONCLUSION: The number of positive lymph nodes is well correlated with tumour progression and provides a useful prognostic indicator after oesophagectomy for oesophageal cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11816540     DOI: 10.1016/s1590-8658(01)80103-1

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  7 in total

1.  Prognostic significance of total disease length in esophageal cancer.

Authors:  L Davies; J D Mason; S A Roberts; D Chan; T D Reid; M Robinson; S Gwynne; T D Crosby; W G Lewis
Journal:  Surg Endosc       Date:  2012-04-26       Impact factor: 4.584

2.  Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer.

Authors:  Christopher P Twine; S Ashley Roberts; Wyn G Lewis; B Vicki Dave; Claire E Rawlinson; David Chan; Mark Robinson; Tom D Crosby
Journal:  Surg Endosc       Date:  2010-04       Impact factor: 4.584

Review 3.  Strategies of nodal staging of the TNM system for esophageal cancer.

Authors:  Wen-Ping Wang; Song-Lin He; Yu-Shang Yang; Long-Qi Chen
Journal:  Ann Transl Med       Date:  2018-02

4.  The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis?

Authors:  Qi-Rong Xu; Xue-Peng Zhuge; He-Lin Zhang; Yu-Min Ping; Long-Qi Chen
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

5.  Histopathological assessment of lymph nodes in upper gastrointestinal cancer: does triple levelling detect significantly more metastases?

Authors:  Stephen McGrath; Sarah Cross; Susan Anne Pritchard
Journal:  J Clin Pathol       Date:  2007-02-13       Impact factor: 3.411

6.  Tumour size of resectable oesophageal squamous cell carcinoma measured with multidetector computed tomography for predicting regional lymph node metastasis and N stage.

Authors:  Hang Li; Tian-wu Chen; Zhen-lin Li; Xiao-ming Zhang; Xiao-li Chen; Li-ying Wang; Li Zhou; Rui Li; Chun-ping Li; Xiao-hua Huang
Journal:  Eur Radiol       Date:  2012-06-01       Impact factor: 5.315

7.  The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma.

Authors:  Ge Song; Wang Jing; Song Xue; Hongbo Guo; Jinming Yu
Journal:  Onco Targets Ther       Date:  2017-05-25       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.